Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

ExpreS2ion Biotechnologies – Presentation of Q2 interim report 2023

By Michael FriisHead of Equities
17.08.2023, 11.30
ExpreS2ion Biotech Holding

Today, ExpreS2ion Biotechnologies released its Q2 2023 results and, more importantly, announced a review of its strategy, pipeline, and organization to materially extend the runway in a tight funding market. This includes, among others, a pause of the breast cancer candidate. With focus on the strategy announcement, the company’s CEO Bent Frandsen and CFO Keith Alexander presented the implications and potential effect of the strategy review, noting that this is in the first inning. 


ExpreS2ion Biotechnologies is a Danish biotechnology company, which focuses on the development of vaccines for diseases such as COVID-19, influenza, and breast cancer through the use of its non-viral Drosophila S2 cells-based expression system.

 

HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis 13.30 PM 28-04-2023.

Storytel, Audiocast, Q2'25
29.07.2025, 09.30 Storytel
Tobii, Audiocast, Q2'25
29.07.2025, 09.00 Tobii
Incap Q2’25: Weaker Currency Weighs on Results
25.07.2025, 13.48 Incap
Vaisala Oyj, Audiocast, Q2'25
25.07.2025, 12.00 Vaisala
Rapala H1'25: Toward a Turning Point
25.07.2025, 11.26 Rapala VMC
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Privacy preferences

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.